EliVGelfandMD

PubMed

• An Unusual Cause of Functional Mitral Stenosis: A Left Atrial Intimal Sarcoma.
  Jamie Diamond, Michael Y Mi, Paul A. VanderLaan, Louis M. Chu, Eli V. Gelfand> ;JACC. Case Reports. 2021 May 1
• 1 citations
  Relation of Transthoracic Echocardiographic Aortic Regurgitation to Pressure Half-time and All-Cause Mortality
  Jordan B. Strom, Eli V. Gelfand, Lawrence J. Markson, Connie A. Tsao, Warren J. Manning> ;The American Journal of Cardiology. 2020 Aug 28
• In Memoriam: Robert L. Berger, 1930-2016.
  Jeremy M. Robbins, Eli V. Gelfand> ;The Journal of Thoracic and Cardiovascular Surgery. 2016 Jul 1
• Severe Mitral Regurgitation in Hypovolemic Shock Masquerading as Mitral Valve Perforation: A Rising Tide Lifts an Anchor
  Colin T. Phillips, Michael C. Gavin, Eli V. Gelfand> ;JAMA Internal Medicine. 2016 Apr 1
• Noninfectious Mitral Annular Disruption: An Unusual Complication of a 25-Meter Fall.
  Eli V. Gelfand, Kamal R. Khabbaz> ;Circulation. 2015 Jul 14
• 50 citations
  Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages
  Elad Anter, Joshua R. Silverstein, Cory M. Tschabrunn, Alexei Shvilkin, Charles I. Haffajee, Peter Zimetbaum, Alfred E. Buxton, Mark E. Josephson, Eli V. Gelfand, Warr...> ;Heart Rhythm. 2014 Nov 1
• 9 citations
  Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support
  Daniel A. Steinhaus, Eli V. Gelfand, Paul A. VanderLaan, Robb D. Kociol> ;The Journal of Heart and Lung Transplantation. 2014 Jul 1
• 17 citations
  Valvular Heart Disease: Classic Teaching and Emerging Paradigms
  D. Marshall Brinkley, Eli V. Gelfand> ;The American Journal of Medicine. 2013 Dec 1
• 1 citations
  Care of Patients With Apparently Asymptomatic Severe Aortic Valve Stenosis
  Mary Ann Williamson, Eli V. Gelfand> ;Clinical Cardiology. 2012 Dec 1
• 7 citations
  Predictors of preserved left ventricular systolic function after surgery for chronic organic mitral regurgitation: a prospective study.
  Eli V. Gelfand, Jessica A Haffajee, Thomas H. Hauser, Susan B. Yeon, Lois Goepfert, Kraig V. Kissinger, Ralph Delatorre, Warren J. Manning> ;The Journal of Heart Valve Disease. 2010 Jan 1
• 2 citations
  Vasculitis Presenting with Ventricular Tachycardia
  Roderick Tung, Ali R Rahimi, Eli V. Gelfand, Kevin F. Kwaku> ;The Journal of Rheumatology. 2009 Sep 1
• 7 citations
  Cardiovascular magnetic resonance imaging for valvular heart disease
  Angela Morello, Eli V. Gelfand> ;Current Heart Failure Reports. 2009 Aug 26
• 24 citations
  Association of TIMI Myocardial Perfusion Grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size ...
  Evan Appelbaum, Ajay J. Kirtane, Alicia Clark, Yuri B. Pride, Eli V. Gelfand, Caitlin J. Harrigan, Kraig V. Kissinger, Warren J. Manning, C. Michael Gibson> ;Journal of Thrombosis and Thrombolysis. 2009 Feb 1
• 2 citations
  Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients.
  Christopher T. Dibble, Eli V. Gelfand, Christopher P. Cannon> ;Current Atherosclerosis Reports. 2007 Aug 29
• 9 citations
  Myocardial infarction: contemporary management strategies.
  Eli V. Gelfand, Christopher P. Cannon> ;Journal of Internal Medicine. 2007 Jul 1
• 9 citations
  Sinus of Valsalva Aneurysm With Right Ventricular Outflow Tract Obstruction Evaluation With Doppler, Real-Time 3-Dimensional and Contrast Echocardiography
  Eli V. Gelfand, Dorota Bzymek, Michael T. Johnstone> ;Circulation. 2006 Dec 26
• 5 citations
  Venous Thromboembolism Guidebook: fifth edition.
  Gregory Piazza, Samuel Z Goldhaber> ;Critical Pathways in Cardiology. 2006 Dec 1
• 9 citations
  Left atrial size and postoperative atrial fibrillation: the volume of evidence suggests it is time to break an old habit.
  Warren J. Manning, Eli V. Gelfand> ;Journal of the American College of Cardiology. 2006 Aug 15
• 76 citations
  Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors.
  Eli V. Gelfand, Christopher P. Cannon> ;Journal of the American College of Cardiology. 2006 May 16
• 46 citations
  Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors.
  Eli V. Gelfand, Christopher P. Cannon> ;Expert Opinion on Investigational Drugs. 2006 Feb 27
• 175 citations
  Severity of Mitral and Aortic Regurgitation as Assessed by Cardiovascular Magnetic Resonance: Optimizing Correlation with Doppler Echocardiography
  Eli V. Gelfand, Sean Hughes, Thomas H. Hauser, Susan B. Yeon, Lois A Goepfert, Kraig V. Kissinger, Neil M. Rofsky, Warren J. Manning> ;Journal of Cardiovascular Magnetic Resonance. 2006 Jan 1
• 114 citations
  Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients...
  C. Michael Gibson, Raphaelle Dumaine, Eli V. Gelfand, Sabina A. Murphy, David A. Morrow, Stephen D. Wiviott, Robert P. Giugliano, Christopher P. Cannon, Elliott M. Ant...> ;European Heart Journal. 2004 Nov 1
• 16 citations
  Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT
  Eli V. Gelfand, Christopher P. Cannon> ;American Heart Journal. 2004 Feb 1
• 6 citations
  Venous Thromboembolism Guidebook, fourth edition.
  Eli V Gelfand, Gregory Piazza, Samuel Z Goldhaber> ;Critical Pathways in Cardiology. 2003 Dec 1
• 5 citations
  Venous thromboembolism guidebook.
  Eli V. Gelfand, Gregory Piazza, Samuel Z. Goldhaber> ;Critical Pathways in Cardiology. 2002 Mar 1
• Join now to see all

Lectures

• Preventive Cardiology Issues in Primary Care - CME Getaways Las Vegas 
  CME Getaways, Las Vegas, Nevada - 10/26/2012